-
Product Insights
Likelihood of Approval Analysis for Cardiovascular Inflammation
Overview How likely is it that the drugs in Cardiovascular Inflammation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cardiovascular Inflammation Overview Cardiovascular inflammation refers to inflammation that occurs in the...
-
Product Insights
Likelihood of Approval Analysis for Hypertriglyceridemia
Overview How likely is it that the drugs in Hypertriglyceridemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertriglyceridemia Overview Hypertriglyceridemia is a condition in which the blood contains high levels...
-
Product Insights
Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KAND-567 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KAND-567 in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KAND-567 in Fallopian Tube Cancer Drug Details: KAND-567 (AZD-8797) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KAND-567 in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KAND-567 in Peritoneal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KAND-567 in Peritoneal Cancer Drug Details: KAND-567 (AZD-8797) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KAND-567 in Myocardial Infarction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KAND-567 in Myocardial Infarction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KAND-567 in Myocardial Infarction Drug Details: KAND-567 (AZD-8797) is under development for...
-
Product Insights
Myocarditis – Drugs In Development, 2023
Global Markets Direct’s, ‘Myocarditis - Drugs In Development, 2023’, provides an overview of the Myocarditis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocarditis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) - Drugs In Development, 2023’, provides an overview of the Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
Behcet Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Behcet Disease - Drugs In Development, 2023’, provides an overview of the Behcet Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Behcet Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...